world and herself ("The world is dangerous," "I cannot protect myself "). For example, we targeted a recurring hallucination of body disintegration and penetration of body boundaries related to the cognition "I am lost," tonic immobility, disgust and panic. EMDR helped the patient to form alternative cognitions like "I can help myself " and significantly reduced aversive emotions. Even though the patient described EMDR sessions as demanding and frightening, she considered them helpful for "finally learning to express in words what happened." After an initial increase of anxiety, hallucinations and dissociative experiences, symptoms decreased. The score for intrusions in the Impact-of-Event Scale-Revised remained stable from first assessment to dismissal (from 31/35 to 29/35) but had decreased significantly 6 months after dismissal (4/35; improvement of 2.6 standard deviation [SD]). The reduction of avoidance symptoms (22/40-15/40) was maintained at follow-up (12/40; improvement of 1.1 SD). Hyperarousal decreased significantly, too (from 26/35 to 19/35 to 5/35; improvement of 1.9 SD). These improvements reflect both reliable and clinically significant changes. In the HEALTH-49, the patient described significant reductions of depressive symptoms (from 3/4 to 0.7/4 to 0.2/4; improvement of 2.8 SD), anxious symptoms (from 3/4 to 1.8/4 to 0.2/4; improvement of 3.0 SD), and interpersonal difficulties (from 3.1/4 to 2.6/4 to 2.1/4; improvement of 0.9 SD). We also observed significant changes in self-efficacy (from 2.2/4 to 3/4 to 3.8/4; improvement of 1.7 SD) and mindfulness (from 61/120 to 83/120 to 99/120; 3.3 SD) which was assessed using the Freiburg Mindfulness Inventory. The Dissociative Experiences Scale-Taxon score decreased from 18% to 1% and remained stable at follow-up (1%). The PANSS score decreased from 64 to 46 which reflects a clinically important difference.
In sum, reprocessing of traumatic memories effectively helped the patient to remit from PTSD and positive psychotic symptoms. Symptom levels had decreased even further at 6-month follow-up. The patient reported that her disturbing "images" had vanished, that she felt well, that she could now "handle everyday life" and that she was doing voluntary work. She decided to end her outpatient CBT treatment but still consults her psychiatrist regularly. As we observed initial increases of psychotic symptoms, inpatient treatment might be a useful option in the treatment of PTSD and psychotic symptoms.
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Sir,
Recent findings suggest a relationship between psychological trauma and schizophrenia spectrum disorders [1] that is partially mediated by posttraumatic stress symptoms. [2] Even though there is evidence that trauma-focused treatments are beneficial for patients with psychotic symptoms, [3] patients with psychosis are still often excluded from first-line treatments of posttraumatic stress disorder (PTSD) due to fears that psychotic symptoms might exacerbate during trauma reprocessing. We want to encourage clinicians to apply trauma-focused therapy to patients with PTSD and psychotic symptoms.
Our patient was a 53-year-old woman diagnosed with PTSD and schizotypal personality disorder according to Diagnostic and Statistical Manual of Mental Disorders, 4 th Edition criteria. She reported flashbacks, insomnia, nightmares, avoidance, hyperarousal, severe derealization and depersonalization, feelings of guilt, constricted affect, obsessive ruminations with aggressive and sexual content, magical thinking, paranoid ideas, social phobia, and visual, body, and acoustic hallucinations. Her trauma history was assessed using the Childhood Trauma Questionnaire and consisted of childhood sexual abuse, emotional abuse and neglect. For more than 20 years, she had had several suicidal crises, inpatient, and outpatient treatments. At the time of admission, her stable medication consisted of 15 mg aripiprazole, 350 mg quetiapine, and 375 mg venlafaxine. She was in early pension and described to profit from outpatient cognitive behavioral therapy (CBT) and medication. Yet, so far nothing had helped to significantly reduce intrusions, nightmares, and hallucinations.
The patient received a multimodal, integrative, and disorder-specific inpatient treatment with various group therapies, for example, psychoeducation, mindfulness training, art therapy, exercise therapy, emotion regulation, and social skills trainings. [4] Case conceptualization followed the Eye Movement Desensitization and Reprocessing (EMDR) guidelines for psychosis [5] and the cognitive model of psychosis. [6] Treatment lasted 12 weeks and consisted of 16 individual 50-min treatment sessions of CBT and ten additional 100-min sessions of EMDR. Symptom levels were assessed daily using an individualized diary card. We used standard EMDR to process traumatic memories of childhood sexual abuse, whereas the goal of reducing psychotic symptoms was targeted by processing hallucinations associated to the patient's dysfunctional beliefs about the
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Clozapine-associated Pisa syndrome: A rare type of tardive dystonia
50 mg to 200 mg/day over 6 months and was maintained on the same for 1½ years.
In the past 6 months, she developed back pain and frequent, forceful bending of spine to the left along with difficulty to walk, and a leaning posture towards the left side which was gradual and progressive. Medical history was significant for adult onset diabetes. Orthopedic, ophthalmic, and neurological examinations were normal. Computed tomography scan of the brain and magnetic resonance imaging of both brain and spine were normal. Full biochemistry profile, liver function test, serum ceruloplasmin, and thyroid functions were normal.
The appearance of dystonia with monotherapy of clozapine for 2 years strongly implicates the role of clozapine. The diagnosis of tardive dystonia can be made based on the criteria by Burke et al. in 1982. [6] The fact that this patient was on clozapine monotherapy for 2 years clearly rules out the involvement of other antipsychotics. It is possible that previous antipsychotic exposure resulted in long-term functional dopamine receptor abnormalities through chronic dopamine receptor blockade. This could have created a sensitizing or priming effect on this patient's striatum.
Sir,
Tardive dystonia are delayed-onset drug-induced movement disorders associated with traditional neuroleptic agents, characterized by involuntary muscle contraction, which may be tonic, spasmodic, patterned, or repetitive. [1] Pleurothotonus or Pisa syndrome is a rare type truncal dystonia, first described by Ekbom et al. in the 1970s. [2] Recent data show that factors such as female gender, old age, previous treatment with classical neuroleptics, the presence of an organic brain disorder, and a combination of pharmacologic treatment increase the risk of this condition. [3] In contrast to other atypicals, such as olanzapine, [4] which have been reported to cause tardive dystonia, clozapine has been used in treating tardive dystonia, including blepharospasm. [5] A 52-year-old woman, with schizophrenia, was on regular treatment with clozapine monotherapy for the last 2 years. Past and family history revealed no psychiatric or neurological illness. She was initially treated with risperidone 8 mg/day and due to partial response switched to quetiapine 200 mg/ day for 1 year which was replaced with clozapine due to partial response. The dose of clozapine was increased from
